Inventor
XUN LIU
Inventor
CN
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G06Fprimary
G06FElectric digital data processing21%
A61KPreparations for medical, dental or toiletry purposes11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C07KPeptides7%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes5%
H04LTransmission of digital information, e.g. telegraphic communication5%
C07BGeneral methods of organic chemistry4%
C07DHeterocyclic compounds4%
H02MApparatus for conversion between ac and ac, between ac and dc, or between dc and dc, and for use with mains or similar power supply systems4%
H04NPictorial communication, e.g. television4%
PatentTitleYear
12,559,539TGF-beta receptor fusion protein pharmaceutical composition and use thereof202612,562,911Fork processing method and blockchain node202612,517,850Interposer routing for universal chiplet interconnect express(tm) channels by partitioning into subchannels202612,406,117Generating and utilizing manufacturable netlists of three-dimensional integrated circuits202512,400,064Routing of high-speed, high-throughput interconnects in integrated circuits202512,240,051Ultrasonic resistance welding process and apparatus202512,187,725Tricyclic urea compounds as JAK2 V617F inhibitors202512,118,283Automatic channel identification of high-bandwidth memory channels for auto-routing202411,902,450Blockchain generation method and system, and related device202411,893,915Image sticking test method and image sticking test device202411,825,183Photographing method and photographing apparatus for adjusting a field of view of a terminal202311,816,407Automatic channel identification of high-bandwidth memory channels for auto-routing202311,780,840Tricyclic urea compounds as JAK2 V617F inhibitors202311,671,081Rail-to-rail source follower buffer for switching regulator driver supply202311,654,194PD-L1 antibody pharmaceutical composition and use thereof202311,620,067Systems and methods for migrating data202311,620,427Pattern based die connector assignment using machine learning image recognition202311,556,093Method and device for calibrating a light smart watch, and light smart watch202311,515,786Techniques for current sensing for single-inductor multiple-output (SIMO) regulators202211,498,961SOST antibody pharmaceutical composition and uses thereof202211,466,666Method and device for stitching wind turbine blade images, and storage medium202211,361,140Routing for length-matched nets in interposer designs202211,273,205IL-15 protein complex pharmaceutical composition202211,272,096Photographing method and photographing apparatus for adjusting a field of view for a terminal202211,200,123Consensus process recovery method and related node2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to HUAWEI TECH CO LTD (5)· patent assignee history
2021–2026Based in CN· patent location history
2022–2026Patents assigned to SYNOPSYS INC (7)· patent assignee history
2022–2026Patents assigned to JIANGSU HENGRUI MEDICINE CO (4)· patent assignee history
2022–2026Patents assigned to Shanghai hengrui pharmaceutical co ltd (4)· patent assignee history
2022–2026Based in US· patent location history
2023–2025Patents assigned to INCYTE CORP (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SYNOPSYS INC | 7 | 2022–2026 |
| HUAWEI TECH CO LTD | 5 | 2021–2026 |
| JIANGSU HENGRUI MEDICINE CO | 4 | 2022–2026 |
| Shanghai hengrui pharmaceutical co ltd | 4 | 2022–2026 |
| INCYTE CORP | 2 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 13 | 2021–2026 |
| US | 12 | 2022–2026 |